Epacadostat Plus Pembrolizumab Is Well Tolerated in a Phase I Trial

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2018-172
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

The EZH2 Inhibitor Tazemetostat Is Well Tolerated in a Phase I Trial

Cancer Discovery
Oncology
2018English

OA05.02 Epacadostat Plus Pembrolizumab in Patients With Non-Small Cell Lung Cancer: Phase 1/2 Results From ECHO-202/KEYNOTE-037

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Imepitoin Is Well Tolerated in Healthy and Epileptic Cats

BMC Veterinary Research
MedicineVeterinary
2017English

Axitinib Plus Pembrolizumab Is Effective in Renal Cell Carcinoma

Cancer Discovery
Oncology
2018English

P1.01-94 Phase I Trial to Establish Maximum Tolerated Dose Safety and Pharmacokinetic Profile of Oral Paclitaxel

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Subcutaneous Treprostinil Is Well Tolerated With Infrequent Site Changes and Analgesics

Pulmonary Circulation
PulmonaryRespiratory Medicine
2013English

Binimetinib Plus Gemcitabine and Cisplatin Phase I/Ii Trial in Patients With Advanced Biliary Cancers

Clinical Cancer Research
Cancer ResearchOncology
2019English

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Pembrolizumab With Rchop in Previously Untreated Diffuse Large B-Cell and Grade 3b Follicular Lymphoma: Final Results of a Phase I Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy